HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ximing J Yang Selected Research

Oxyphilic Adenoma (Oncocytoma)

5/2010Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma.
12/2007Vimentin reactivity in renal oncocytoma: immunohistochemical study of 234 cases.
8/2006Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma.
7/2006Expression of kidney-specific cadherin in chromophobe renal cell carcinoma and renal oncocytoma.
3/2005C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ximing J Yang Research Topics

Disease

48Neoplasms (Cancer)
02/2018 - 11/2002
24Prostatic Neoplasms (Prostate Cancer)
05/2020 - 06/2002
24Renal Cell Carcinoma (Grawitz Tumor)
11/2014 - 01/2004
14Carcinoma (Carcinomatosis)
02/2018 - 09/2002
14Adenocarcinoma
12/2016 - 07/2002
9Kidney Neoplasms (Kidney Cancer)
11/2015 - 06/2004
6Neoplasm Metastasis (Metastasis)
05/2010 - 07/2006
5Prostatic Intraepithelial Neoplasia
01/2021 - 09/2002
5Small Cell Carcinoma
01/2018 - 03/2005
5Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
11/2014 - 03/2003
5Oxyphilic Adenoma (Oncocytoma)
05/2010 - 03/2005
4Carcinogenesis
05/2012 - 05/2007
3Hepatocellular Carcinoma (Hepatoma)
11/2014 - 08/2008
3Glandular and Epithelial Neoplasms (Neoplasms, Glandular)
02/2008 - 04/2006
3renal Oncocytoma
12/2007 - 07/2006
2Melanoma (Melanoma, Malignant)
11/2020 - 11/2014
2Residual Neoplasm
11/2020 - 10/2012
2Angiomyolipoma
01/2016 - 03/2005
2Wilms Tumor (Wilm's Tumor)
01/2015 - 06/2008
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2014 - 08/2013
2Inflammation (Inflammations)
11/2010 - 09/2010
2Placental Site Trophoblastic Tumor
09/2010 - 10/2007
2Colorectal Neoplasms (Colorectal Cancer)
12/2009 - 09/2005
2Adenoma (Adenomas)
02/2007 - 09/2004
2Sickle Cell Trait
06/2005 - 03/2004
2Margins of Excision
01/2004 - 11/2002
2Hyperplasia
05/2003 - 07/2002
1Noninfiltrating Intraductal Carcinoma (DCIS)
01/2021
1Necrosis
01/2021
1Teratoma (Teratoid Tumor)
11/2020
1Autosomal Dominant Polycystic Kidney (ADPKD)
01/2020
1Chronic Kidney Failure (Chronic Renal Failure)
01/2020
1Cystic Kidney Diseases (Cystic Kidney Disease)
01/2020
1Lung Neoplasms (Lung Cancer)
01/2018
1Herpes Simplex
01/2018
1Neuroblastoma
01/2018
1Tuberous Sclerosis (Bourneville's Disease)
01/2016
1Birt-Hogg-Dube Syndrome
11/2015
1Choriocarcinoma
11/2014
1Liver Neoplasms (Liver Cancer)
11/2014
1Endodermal Sinus Tumor (Endodermal Sinus Tumors)
11/2014
1Simpson-Golabi-Behmel syndrome
11/2014

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
11/2015 - 07/2002
10Messenger RNA (mRNA)IBA
01/2018 - 01/2004
10Racemases and Epimerases (Epimerases and Racemases)IBA
12/2006 - 06/2002
9alpha-methylacyl-CoA racemaseIBA
02/2018 - 07/2002
9Complementary DNA (cDNA)IBA
02/2008 - 09/2002
9Coenzyme A (CoA)IBA
12/2006 - 06/2002
8Biomarkers (Surrogate Marker)IBA
01/2019 - 03/2004
8GlypicansIBA
01/2015 - 12/2006
7Keratins (Keratin)IBA
10/2009 - 09/2002
6Biological ProductsIBA
05/2010 - 05/2005
3Phenobarbital (Luminal)FDA Link
01/2021 - 05/2003
3Androgen Receptors (Androgen Receptor)IBA
01/2019 - 01/2006
3Carrier Proteins (Binding Protein)IBA
12/2016 - 04/2005
3DNA (Deoxyribonucleic Acid)IBA
01/2011 - 03/2004
3Prostate-Specific Antigen (Semenogelase)IBA
11/2006 - 09/2002
2enzalutamideIBA
05/2020 - 01/2019
2AntigensIBA
01/2018 - 12/2009
2Sirolimus (Rapamycin)FDA Link
11/2015 - 01/2006
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2013 - 05/2012
2TOR Serine-Threonine KinasesIBA
05/2012 - 01/2006
2Hormones (Hormone)IBA
01/2012 - 04/2005
2ErbB Receptors (EGF Receptor)IBA
09/2010 - 02/2007
2Hemoglobins (Hemoglobin)IBA
02/2010 - 06/2005
2Combined Antibody TherapeuticsIBA
10/2009 - 12/2006
2MicroRNAs (MicroRNA)IBA
07/2009 - 06/2008
2VimentinIBA
05/2009 - 12/2007
2Transforming Growth Factor beta (TGF-beta)IBA
05/2009 - 07/2006
2RNA (Ribonucleic Acid)IBA
06/2008 - 08/2003
2Insulin-Like Growth Factor Binding Protein 3IBA
02/2008 - 04/2005
2EnzymesIBA
05/2007 - 02/2006
2Indicators and Reagents (Reagents)IBA
01/2007 - 08/2003
2AntibodiesIBA
12/2006 - 07/2005
2Keratin-7 (Cytokeratin 7)IBA
08/2006 - 07/2005
2Monoclonal AntibodiesIBA
04/2005 - 03/2005
1GP 4 (GP4)IBA
01/2021
1Chemokine ReceptorsIBA
01/2019
1Fatty Acids (Saturated Fatty Acids)IBA
02/2018
1Anaplastic Lymphoma KinaseIBA
01/2018
1alectinibIBA
01/2018
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2018
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2018
1Chimeric Antigen ReceptorsIBA
01/2018
1Thymidine KinaseIBA
01/2018
1Phosphopyruvate Hydratase (Enolase)IBA
01/2018
1Coloring Agents (Dyes)IBA
09/2017
1Calcibiotic Root Canal SealerIBA
12/2016
1EverolimusFDA Link
01/2016
1MTOR InhibitorsIBA
01/2016
1OligonucleotidesIBA
01/2015
1Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA
11/2014

Therapy/Procedure

12Therapeutics
01/2016 - 03/2004
9Prostatectomy (Retropubic Prostatectomy)
10/2012 - 07/2002
7Nephrectomy
01/2020 - 06/2006
4Drug Therapy (Chemotherapy)
11/2020 - 09/2004
2Cystectomy
09/2004 - 08/2003
2Radiotherapy
09/2004 - 03/2003
1Castration
01/2019
1Immunotherapy
01/2018